Evolent Health Inc - Ordinary Shares - Class A

NYSE:EVH   3:59:54 PM EDT
34.47
+1.36 (+4.11%)
Other Pre-Announcement

Evolent Health Announces Second Quarter 2022 Results

Published: 08/02/2022 21:37 GMT
Evolent Health Inc - Ordinary Shares - Class A (EVH) - Evolent Health Announces Second Quarter 2022 Results.
Qtrly Revenue of $319.9 Million, an Increase of 44.1%.
Sees Q3 Revenue to Be in Range of Approximately $343.0 Million to $363.0 Million.
Revenue for Year Ending December 31, 2022 is Expected to Be in Range of Approximately $1.32 Billion to $1.36 Billion.
Qtrly Loss per Share for Continuing Operations $0.05.
Q2 Earnings per Share View $0.05, Revenue View $297.8 Million -- Refinitiv Ibes Data (analyst estimates).
Q3 Revenue View $312.7 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $1.22 Billion -- Refinitiv Ibes Data (analyst estimates).
Qtrly Adjusted Income per Share Attributable to Common Shareholders of $0.10.